Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 19, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/suppl_2/R239    most recent
ddg288v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Goberdhan, D. C.I.
Right arrow Articles by Wilson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goberdhan, D. C.I.
Right arrow Articles by Wilson, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, Review Issue 2 R239-R248
DOI: 10.1093/hmg/ddg288
© 2003 Oxford University Press

PTEN: tumour suppressor, multifunctional growth regulator and more

Deborah C.I. Goberdhan* and Clive Wilson

Department of Human Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK

Received June 30, 2003; Accepted August 14, 2003

The tumour suppressor gene PTEN is mutated in a wide range of human cancers at a frequency roughly comparable with p53. In addition, germline PTEN mutations are associated with several dominant growth disorders. The molecular and cellular basis of these disorders has been elucidated by detailed in vivo genetic analysis in model organisms, in particular the fruit fly and mouse. Studies in the fly have shown that PTEN's growth regulatory functions are primarily mediated via its lipid phosphatase activity, which specifically reduces the cellular levels of phosphatidylinositol 3,4,5-trisphosphate. This activity antagonizes the effects of activated PI3-kinase in the nutritionally controlled insulin receptor pathway, thereby reducing protein synthesis and restraining cell and organismal growth, while also regulating other biological processes, such as fertility and ageing. Remarkably, this range of functions appears to be conserved in all higher organisms. PTEN also plays a role as a specialized cytoskeletal regulator, which, for example, is involved in directional movement of some migratory cells and may be important in metastasis. Furthermore, conditional knockouts in the mouse have recently revealed functions for PTEN in other processes, such as cell type specification and cardiac muscle contractility. Genetic approaches have therefore revealed a surprising diversity of global and cell type-specific PTEN-regulated functions that appear to be primarily controlled by modulation of a single phosphoinositide. Together with evidence from studies in cell culture that suggests links between PTEN and other growth regulatory genes such as p53, these studies provide new insights into PTEN-linked disorders and are beginning to suggest potential clinical strategies to combat these and other diseases.

* To whom correspondence should be addressed. Tel: +44 1865282661; Fax: +44 1865272420; Email: deborah.goberdhan{at}anat.ox.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
Z. S. Boyd, Q. J. Wu, C. O'Brien, J. Spoerke, H. Savage, P. J. Fielder, L. Amler, Y. Yan, and M. R. Lackner
Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays
Mol. Cancer Ther., December 1, 2008; 7(12): 3695 - 3706.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
T. A. Davis, A. Suryawan, R. A. Orellana, H. V. Nguyen, and M. L. Fiorotto
Postnatal ontogeny of skeletal muscle protein synthesis in pigs
J Anim Sci, April 1, 2008; 86(14_suppl): E13 - E18.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
V. Dave, S. E. Wert, T. Tanner, A. R. Thitoff, D. E. Loudy, and J. A. Whitsett
Conditional Deletion of Pten Causes Bronchiolar Hyperplasia
Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 337 - 345.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
N. Vereshchagina and C. Wilson
Cytoplasmic activated protein kinase Akt regulates lipid-droplet accumulation in Drosophila nurse cells
Development, December 1, 2006; 133(23): 4731 - 4735.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Suryawan, J. Escobar, J. W. Frank, H. V. Nguyen, and T. A. Davis
Developmental regulation of the activation of signaling components leading to translation initiation in skeletal muscle of neonatal pigs
Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E849 - E859.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
L. C. Huber, O. Distler, I. Tarner, R. E. Gay, S. Gay, and T. Pap
Synovial fibroblasts: key players in rheumatoid arthritis
Rheumatology, June 1, 2006; 45(6): 669 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
K. Nadra, S. I. Anghel, E. Joye, N. S. Tan, S. Basu-Modak, D. Trono, W. Wahli, and B. Desvergne
Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor {beta}/{delta}
Mol. Cell. Biol., April 15, 2006; 26(8): 3266 - 3281.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. Sova, Q. Feng, G. Geiss, T. Wood, R. Strauss, V. Rudolf, A. Lieber, and N. Kiviat
Discovery of Novel Methylation Biomarkers in Cervical Carcinoma by Global Demethylation and Microarray Analysis
Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 114 - 123.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Valiente, A. Andres-Pons, B. Gomar, J. Torres, A. Gil, C. Tapparel, S. E. Antonarakis, and R. Pulido
Binding of PTEN to Specific PDZ Domains Contributes to PTEN Protein Stability and Phosphorylation by Microtubule-associated Serine/Threonine Kinases
J. Biol. Chem., August 12, 2005; 280(32): 28936 - 28943.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. J. Phillips, J. Mestas, M. Gharaee-Kermani, M. D. Burdick, A. Sica, J. A. Belperio, M. P. Keane, and R. M. Strieter
Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1{alpha}
J. Biol. Chem., June 10, 2005; 280(23): 22473 - 22481.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
D. C. I. Goberdhan, D. Meredith, C. A. R. Boyd, and C. Wilson
PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids
Development, May 15, 2005; 132(10): 2365 - 2375.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Shah, W. A. Swain, D. Richardson, J. Edwards, D. J. Stewart, C. M. Richardson, D. E.B. Swinson, D. Patel, J. L. Jones, and K. J. O'Byrne
Phospho-Akt Expression Is Associated with a Favorable Outcome in Non-Small Cell Lung Cancer
Clin. Cancer Res., April 15, 2005; 11(8): 2930 - 2936.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.